Moleculin Biotech
MBRX
MBRX
31 hedge funds and large institutions have $5.16M invested in Moleculin Biotech in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
31
Holders Change
+7
Holders Change %
+29.17%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$237K |
2 |
2
Renaissance Technologies
New York
|
$1.04M |
3 |
3
Jane Street
New York
|
$42K |
4 |
4
Bank of New York Mellon
New York
|
$78K |
5 |
ARTA
5
A.R.T. Advisors
New York
|
$31K |
Top Sellers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.89M |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
3 |
3
BlackRock
New York
|
$118K |
4 |
ACS
4
Archford Capital Strategies
Swansea,
Illinois
|
$0 |